Literature DB >> 27045472

Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis.

Marco Cordani1, Raffaella Pacchiana1, Giovanna Butera1, Gabriella D'Orazi2, Aldo Scarpa3, Massimo Donadelli4.   

Abstract

An ever-increasing number of studies highlight the role of mutant p53 proteins in the alteration of cancer cell secretome and in the modification of tumour microenvironment, sustaining an invasive phenotype of cancer cell. The knowledge of the molecular mechanisms underlying the interplay between mutant p53 proteins and the microenvironment is becoming fundamental for the identification of both efficient anticancer therapeutic strategies and novel serum biomarkers. In this review, we summarize the novel findings concerning the regulation of secreted molecules by cancer cells bearing mutant TP53 gene. In particular, we highlight data from available literature, suggesting that mutant p53 proteins are able to (i) alter the secretion of enzymes involved in the modulation of extracellular matrix components; (ii) alter the secretion of inflammatory cytokines; (iii) increase the extracellular acidification; and (iv) regulate the crosstalk between cancer and stromal cells.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Cytokines; Microenvironment; Mutant p53; Secretome

Mesh:

Substances:

Year:  2016        PMID: 27045472     DOI: 10.1016/j.canlet.2016.03.046

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  26 in total

1.  Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies.

Authors:  Gabriella D'Orazi; Marco Cordani; Mara Cirone
Journal:  Cell Mol Life Sci       Date:  2020-10-17       Impact factor: 9.261

2.  Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer.

Authors:  R Shakya; G A Tarulli; L Sheng; N A Lokman; C Ricciardelli; K I Pishas; C I Selinger; M R J Kohonen-Corish; W A Cooper; A G Turner; P M Neilsen; D F Callen
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

3.  Occurrence of quadruple squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation for leukemia: A case report.

Authors:  Chunhong Hu; Xue Wang; Yue Pan; Long Shu; Fang Wu
Journal:  Oncol Lett       Date:  2021-03-02       Impact factor: 3.111

4.  Reactivation of mutant p53 by capsaicin, the major constituent of peppers.

Authors:  Alessia Garufi; Giuseppa Pistritto; Mara Cirone; Gabriella D'Orazi
Journal:  J Exp Clin Cancer Res       Date:  2016-09-06

5.  Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumors.

Authors:  Shumpei Ohnami; Keiichi Ohshima; Takeshi Nagashima; Kenichi Urakami; Yuji Shimoda; Junko Saito; Akane Naruoka; Keiichi Hatakeyama; Tohru Mochizuki; Masakuni Serizawa; Sumiko Ohnami; Masatoshi Kusuhara; Ken Yamaguchi
Journal:  Mol Cell Biochem       Date:  2017-03-03       Impact factor: 3.396

6.  DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.

Authors:  Joana Soares; Margarida Espadinha; Liliana Raimundo; Helena Ramos; Ana Sara Gomes; Sara Gomes; Joana B Loureiro; Alberto Inga; Flávio Reis; Célia Gomes; Maria M M Santos; Lucília Saraiva
Journal:  Mol Oncol       Date:  2017-05-02       Impact factor: 6.603

7.  Targeting the mutant p53 secretome.

Authors:  Kartik Sehgal; David A Barbie
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 8.  The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy.

Authors:  Maurice Michel; Leonard Kaps; Annett Maderer; Peter R Galle; Markus Moehler
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

9.  Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.

Authors:  Tomer Cooks; Ioannis S Pateras; Lisa M Jenkins; Keval M Patel; Ana I Robles; James Morris; Tim Forshew; Ettore Appella; Vassilis G Gorgoulis; Curtis C Harris
Journal:  Nat Commun       Date:  2018-02-22       Impact factor: 14.919

10.  p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi.

Authors:  Xiaochao Tan; Priyam Banerjee; Lei Shi; Guan-Yu Xiao; B Leticia Rodriguez; Caitlin L Grzeskowiak; Xin Liu; Jiang Yu; Don L Gibbons; William K Russell; Chad J Creighton; Jonathan M Kurie
Journal:  Sci Adv       Date:  2021-06-18       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.